Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Baptist Memorial Hospital-Golden Triangle located at 2520 5Th St N, Columbus, MS, 39705 & includes data from NPIs 1609830173, 1609963479
Oct 2016 to Sep 2019   |   Oct 2018 to Sep 2019
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 11,284 | 10,744 | ||||||||||||||||||||||
Surgical | 3,365 | 3,278 | ||||||||||||||||||||||
Non Surgical | 7,919 | 7,466 | ||||||||||||||||||||||
General Medicine | 2,223 | 2,049 | ||||||||||||||||||||||
Cardiovascular | 1,868 | 1,754 | ||||||||||||||||||||||
Orthopedics | 1,165 | 1,149 | ||||||||||||||||||||||
Pulmonology | 1,056 | 1,000 | ||||||||||||||||||||||
Psychiatry & Mental Disorders | 978 | 937 | ||||||||||||||||||||||
Gastroenterology & Endocrinology | 923 | 899 | ||||||||||||||||||||||
Urology | 803 | 779 | ||||||||||||||||||||||
Spine | 703 | 695 | ||||||||||||||||||||||
General Surgery | 545 | 518 | ||||||||||||||||||||||
Neurology | 513 | 486 | ||||||||||||||||||||||
Oncology & Hematology | 259 | 243 | ||||||||||||||||||||||
Colorectal | 158 | 152 | ||||||||||||||||||||||
Obstetrics & Gynecology | 57 | 55 | ||||||||||||||||||||||
Dermatology | 17 | 16 | ||||||||||||||||||||||
Obesity, Bariatric, Stomach & Duodenal | 16 | 12 |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cellulitis | ||||||||||||||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||||||||||||||
DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Complications Of Treatment | ||||||||||||||||||||||||
DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Signs And Symptoms | ||||||||||||||||||||||||
Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Postoperative And Post-Traumatic Infections | ||||||||||||||||||||||||
Peptic Ulcer | ||||||||||||||||||||||||
Fever And Inflammatory Conditions | ||||||||||||||||||||||||
DRG 864: FEVER |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Coronary Bypass | ||||||||||||||||||||||||
DRG 234: CORONARY BYPASS WITH CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 233: CORONARY BYPASS WITH CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Acute Myocardial Infarction | ||||||||||||||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 282: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Vascular Procedures | ||||||||||||||||||||||||
DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 254: OTHER VASCULAR PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Hypertension | ||||||||||||||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 304: HYPERTENSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 244: PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Circulatory System Diagnoses | ||||||||||||||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Heart Assist System Implant | ||||||||||||||||||||||||
DRG 215: OTHER HEART ASSIST SYSTEM IMPLANT | ||||||||||||||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||||||||||||||
DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Syncope And Collapse | ||||||||||||||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
Peripheral Vascular Disorders | ||||||||||||||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 299: PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Aortic And Heart Assist Procedures | ||||||||||||||||||||||||
DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||||||||||||||
Percutaneous Cardiovascular Procedures Without Coronary Artery Stent | ||||||||||||||||||||||||
DRG 251: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITHOUT CORONARY ARTERY STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cardiac Defibrillator Implant | ||||||||||||||||||||||||
Other Circulatory O.R. Procedures | ||||||||||||||||||||||||
DRG 264: OTHER CIRCULATORY SYSTEM O.R. PROCEDURES | ||||||||||||||||||||||||
Chest Pain | ||||||||||||||||||||||||
DRG 313: CHEST PAIN |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 480: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||||||||||||||
Amputation For Circulatory System Disorders Except Upper Limb And Toe | ||||||||||||||||||||||||
DRG 239: AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 240: AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||||||||||||||
DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||||||||||||||
DRG 493: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 535: FRACTURES OF HIP AND PELVIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Medical Back Problems | ||||||||||||||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Amputation Of Lower Limb For Endocrine, Nutritional And Metabolic Disorders | ||||||||||||||||||||||||
DRG 617: AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Soft Tissue Procedures | ||||||||||||||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pulmonary Edema And Respiratory Failure | ||||||||||||||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||||||||||||||
Respiratory Infections And Inflammations | ||||||||||||||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pulmonary Embolism | ||||||||||||||||||||||||
DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Pneumothorax | ||||||||||||||||||||||||
DRG 200: PNEUMOTHORAX WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pleural Effusion | ||||||||||||||||||||||||
DRG 186: PLEURAL EFFUSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||||||||||||||
DRG 885: PSYCHOSES | ||||||||||||||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||||||||||||||
DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | ||||||||||||||||||||||||
Neuroses Except Depressive | ||||||||||||||||||||||||
DRG 882: NEUROSES EXCEPT DEPRESSIVE | ||||||||||||||||||||||||
Depressive Neuroses | ||||||||||||||||||||||||
DRG 881: DEPRESSIVE NEUROSES |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G.I.Hemorrhage | ||||||||||||||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
G.I. Obstruction | ||||||||||||||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 388: G.I. OBSTRUCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cholecystectomy | ||||||||||||||||||||||||
DRG 418: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 419: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 416: CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 414: CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Diabetes | ||||||||||||||||||||||||
DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||||||||||||||
DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 438: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 440: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Digestive System Diagnoses | ||||||||||||||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||||||||||||||
DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 371: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Disorders Of Biliary Tract | ||||||||||||||||||||||||
Endocrine Disorders | ||||||||||||||||||||||||
Major Esophageal Disorders |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 684: RENAL FAILURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Kidney And Ureter Procedures | ||||||||||||||||||||||||
DRG 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Male Pelvic Procedures | ||||||||||||||||||||||||
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 459: SPINAL FUSION EXCEPT CERVICAL WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Combined Anterior/Posterior Spinal Fusion | ||||||||||||||||||||||||
DRG 454: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 455: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 453: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cervical Spinal Fusion | ||||||||||||||||||||||||
DRG 473: CERVICAL SPINAL FUSION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Spinal Procedures | ||||||||||||||||||||||||
DRG 029: SPINAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) OR SPINAL NEUROSTIMULATORS | ||||||||||||||||||||||||
Spinal Fusion Except Cervical With Spinal Curvature / Malignancy / Infection Or Extensive Fusions |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 854: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Extracranial Procedures | ||||||||||||||||||||||||
DRG 038: EXTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 039: EXTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Peritoneal Adhesiolysis | ||||||||||||||||||||||||
Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||||||||||||||
DRG 856: POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other O.R. Procedures For Injuries | ||||||||||||||||||||||||
DRG 908: OTHER O.R. PROCEDURES FOR INJURIES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Major Chest Procedures | ||||||||||||||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Digestive System O.R. Procedures | ||||||||||||||||||||||||
DRG 356: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Hernia Procedures | ||||||||||||||||||||||||
Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||||||||||||||
DRG 580: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||||||||||||||
DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
Skin Debridement | ||||||||||||||||||||||||
Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Transient Ischemia | ||||||||||||||||||||||||
DRG 069: TRANSIENT ISCHEMIA | ||||||||||||||||||||||||
Other Disorders Of Nervous System | ||||||||||||||||||||||||
DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Degenerative Nervous System Disorders | ||||||||||||||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Seizures | ||||||||||||||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Nonspecific Cerebrovascular Disorders | ||||||||||||||||||||||||
Hypertensive Encephalopathy |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Digestive Malignancy | ||||||||||||||||||||||||
DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Coagulation Disorders | ||||||||||||||||||||||||
DRG 813: COAGULATION DISORDERS | ||||||||||||||||||||||||
Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||||||||||||||
Chemotherapy Without Acute Leukemia As Secondary Diagnosis |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uterine And Adnexal Procedures For Non-Malignancy | ||||||||||||||||||||||||
DRG 743: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures | ||||||||||||||||||||||||
DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |